Recent from talks
Cervical cancer staging
Knowledge base stats:
Talk channels stats:
Members stats:
Cervical cancer staging
Cervical cancer staging is the assessment of cervical cancer to determine the extent of the spread of cancer beyond the cervix. This is important for determining how serious the cancer is and to create the best treatment plan.
Cervical cancer is a type of gynecological cancer that begins from cells lining the cervix, the lower part of the uterus. Cervical cancer begins when the cells that line the cervix become abnormal and grow in a pattern that is atypical for non-cancerous cells. Cervical cancer is typically first identified with an abnormal pap smear. The final diagnosis of cervical cancer, including the stage of the cancer, is confirmed with additional testing.
Cancer staging is determined by where the tumor is located, the size of the tumor, and how much the tumor has spread beyond where it originally began, such as to nearby lymph nodes or different parts of the body.
Cancer staging is described on a spectrum from stage 0 to stage IV. Stage 0 describes pre-cancerous or non-invasive types of tumors. Stage IV is used to describe cancers that have spread throughout a significant part of the body. In general, the greater the stage of cancer, the more aggressive the disease and the worse the prognosis.
Cervical cancer staging is described by the International Federation of Gynecology and Obstetrics (FIGO). In 2018, FIGO released the most recent guidelines for cervical cancer staging. These guidelines recommend the use of various physical examinations, types of imaging, and biopsies to determine the stage of cervical cancer.
Cervical cancer is the abnormal growth of the cells that line the cervix, resulting in the cells growing out of control and potentially spreading to areas outside of the cervix.
The cervix is the lower part of the uterus. It connects the upper part of the uterus with the vagina. The cervix is divided into two parts based on the types of cells. The outer portion of the cervix is called the ectocervix, while the inner portion of the cervix is the endocervix. These two portions of the cervix have different types of cells. The area where the endocervix and ectocervix meet is known as the transformation zone. Most cervical cancers arise from the cells in the transformation zone.
Cervical cancer screening occurs with pap smears performed by an obstetrician-gynecologist. During a pap smear, doctors collect a sample of the cells from the cervix to look at under a microscope to examine for any abnormalities or signs of pre-cancerous changes. While many abnormalities on pap smears are not indicative of cervical cancer, the doctor may recommend additional testing to gain a better understanding of the cervical cells. Additional testing that may be performed includes an endocervical curettage, colposcopy, or cervical conization. Each of these procedures allows for the collection of a biopsy of the cells of the cervix.
Hub AI
Cervical cancer staging AI simulator
(@Cervical cancer staging_simulator)
Cervical cancer staging
Cervical cancer staging is the assessment of cervical cancer to determine the extent of the spread of cancer beyond the cervix. This is important for determining how serious the cancer is and to create the best treatment plan.
Cervical cancer is a type of gynecological cancer that begins from cells lining the cervix, the lower part of the uterus. Cervical cancer begins when the cells that line the cervix become abnormal and grow in a pattern that is atypical for non-cancerous cells. Cervical cancer is typically first identified with an abnormal pap smear. The final diagnosis of cervical cancer, including the stage of the cancer, is confirmed with additional testing.
Cancer staging is determined by where the tumor is located, the size of the tumor, and how much the tumor has spread beyond where it originally began, such as to nearby lymph nodes or different parts of the body.
Cancer staging is described on a spectrum from stage 0 to stage IV. Stage 0 describes pre-cancerous or non-invasive types of tumors. Stage IV is used to describe cancers that have spread throughout a significant part of the body. In general, the greater the stage of cancer, the more aggressive the disease and the worse the prognosis.
Cervical cancer staging is described by the International Federation of Gynecology and Obstetrics (FIGO). In 2018, FIGO released the most recent guidelines for cervical cancer staging. These guidelines recommend the use of various physical examinations, types of imaging, and biopsies to determine the stage of cervical cancer.
Cervical cancer is the abnormal growth of the cells that line the cervix, resulting in the cells growing out of control and potentially spreading to areas outside of the cervix.
The cervix is the lower part of the uterus. It connects the upper part of the uterus with the vagina. The cervix is divided into two parts based on the types of cells. The outer portion of the cervix is called the ectocervix, while the inner portion of the cervix is the endocervix. These two portions of the cervix have different types of cells. The area where the endocervix and ectocervix meet is known as the transformation zone. Most cervical cancers arise from the cells in the transformation zone.
Cervical cancer screening occurs with pap smears performed by an obstetrician-gynecologist. During a pap smear, doctors collect a sample of the cells from the cervix to look at under a microscope to examine for any abnormalities or signs of pre-cancerous changes. While many abnormalities on pap smears are not indicative of cervical cancer, the doctor may recommend additional testing to gain a better understanding of the cervical cells. Additional testing that may be performed includes an endocervical curettage, colposcopy, or cervical conization. Each of these procedures allows for the collection of a biopsy of the cells of the cervix.
Recent media